Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Park
    Park
  2. Sadelain
    Sadelain
  3. Wang
    Wang
  4. Bernal
    Bernal
  5. Curran
    Curran
  6. Santomasso
    Santomasso

Groups

  1. Adult Leukemia (5)
  2. Center for Hematologic Malignancies (5)
  3. Department of Medicine (5)
  4. GSK Faculty (5)
  5. Hematologic Malignancies Research (5)
  6. Hematologic Malignancies, Division of (5)
  7. Molecular Pharmacology and Chemistry Program Faculty (5)
  8. Sloan Kettering Institute Faculty (5)
  9. Advanced Practice Providers (1)
  10. Bone Marrow Transplant (1)
Search Within
  1. "Renier Brentjens"
Formats
  1. Meeting Abstract (5)
Groups
  1. Adult Leukemia (5)
  2. Center for Hematologic Malignancies (5)
  3. Department of Medicine (5)
  4. GSK Faculty (5)
  5. Hematologic Malignancies Research (5)
  6. Hematologic Malignancies, Division of (5)

More Groups

People
  1. Isabelle Riviere (5)
  2. Jae Park (5)
  3. Michel Sadelain (5)
  4. Renier Brentjens (5)
  5. Xiuyan Wang (5)
  6. Brigitte Senechal (2)

More People

Years
  1. 2017 (2)
  2. 2016 (1)
  3. 2015 (1)
  4. 2014 (1)
Publications
  1. Haematologica (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Durable long-term survival of adult patients with B-ALL after CD19 CAR (19-28z) T cell therapy
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Purdon, T.; Brentjens, R.; Sadelain, M.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Baseline and early post-treatment clinical and laboratory factors associated with severe neurotoxicity following 19-28z CAR T cells in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Santomasso, B.; Sadelain, M.; Brentjens, R.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Impact of disease burden on long-term outcome of CD19-targeted CAR modified T cells in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Sadelain, M.; Brentjens, R.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Phase I trial of autologous Cd19-targeted car-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated cll
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X.; Bartido, S.; Sadelain, M.; Brentjens, R. J.
    Haematologica (2014)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: